Product Description: Dalutrafusp alfa (AGEN-1423; GS-1423) is a specific bifunctional antibody against CD73 and TGF-β, which is involved in the immunosuppressive pathway[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Anthony W Tolcher, et al. Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors. J Immunother Cancer. 2023 Feb;11(2):e005267.
CAS Number: 2419918-89-9
Molecular Weight: N/A
Compound Purity: 96.83
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: CD73;TGF-β Receptor